Staphylococcus lugdunensis

The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

Background


Antibiotic susceptibility pattern of 540 Staphylococcus lugdunensis isolates tested with the disc diffusion method:[2]

Antibiotic No. (%) susceptible
Penicillin G 403 (74.6)
Gentamicin 538 (99.6)
Rifampicin 538 (99.6)
Cefoxitin 538 (99.6)
Fusidic acid 528 (97.8)
Trimethoprim/sulfamethoxazole 539 (99.8)
Norfloxacin 539 (99.8)
Clindamycin 494 (91.5)
Erythromycin 506 (93.7)


Antibiotic Sensitivities[3]

Key

  • S susceptible/sensitive (usually)
  • I intermediate (variably susceptible/resistant)
  • R resistant (or not effective clinically)
  • S+ synergistic with cell wall antibiotics
  • U sensitive for UTI only (non systemic infection)
  • X1 no data
  • X2 active in vitro, but not used clinically
  • X3 active in vitro, but not clinically effective for Group A strep pharyngitis or infections due to E. faecalis
  • X4 active in vitro, but not clinically effective for strep pneumonia

Table Overview

See Also

References

  1. Taha L, Stegger M, and Soderquist B. Staphylococcus lugdunensis: antimicrobial susceptibility and optimal treatment options, European Journal of Clinical Microbiology & Infectious Diseases, May 2019. Accessed 21 December 2020.
  2. Taha L, Stegger M, and Soderquist B. Staphylococcus lugdunensis: antimicrobial susceptibility and optimal treatment options, European Journal of Clinical Microbiology & Infectious Diseases, May 2019. Accessed 21 December 2020.
  3. Sanford Guide to Antimicrobial Therapy 2010